BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27055532)

  • 1. Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients.
    Kuijpers YA; Meijer RP; Jonges GN; de Jong J; Bosch JL; Horenblas S; Bex A
    World J Urol; 2016 Aug; 34(8):1073-9. PubMed ID: 27055532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Outcomes of Follow-up for Initially Localised Clear Cell Renal Cell Carcinoma: RECUR Database Analysis.
    Dabestani S; Beisland C; Stewart GD; Bensalah K; Gudmundsson E; Lam TB; Gietzmann W; Zakikhani P; Marconi L; Fernandéz-Pello S; Monagas S; Williams SP; Torbrand C; Powles T; Van Werkhoven E; Meijer R; Volpe A; Staehler M; Ljungberg B; Bex A
    Eur Urol Focus; 2019 Sep; 5(5):857-866. PubMed ID: 29525381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.
    Eggener SE; Yossepowitch O; Pettus JA; Snyder ME; Motzer RJ; Russo P
    J Clin Oncol; 2006 Jul; 24(19):3101-6. PubMed ID: 16809736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study.
    Dabestani S; Thorstenson A; Lindblad P; Harmenberg U; Ljungberg B; Lundstam S
    World J Urol; 2016 Aug; 34(8):1081-6. PubMed ID: 26847337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.
    Russell CM; Lue K; Fisher J; Kassouf W; Schwaab T; Sexton WJ; Tanguay S; Psutka SP; Thompson RH; Leibovich BC; Hanzly MI; Spiess PE; Boorjian SA
    BJU Int; 2016 Jun; 117(6B):E60-6. PubMed ID: 26118331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma.
    Schrodter S; Hakenberg OW; Manseck A; Leike S; Wirth MP
    J Urol; 2002 Apr; 167(4):1630-3. PubMed ID: 11912377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging strategy and outcome following partial nephrectomy.
    Mouracade P; Chavali JS; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Rini BI; Kaouk JH
    Urol Oncol; 2017 Nov; 35(11):660.e1-660.e8. PubMed ID: 28863862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of local recurrence following radical nephrectomy or partial nephrectomy.
    Campbell SC; Novick AC
    Urol Clin North Am; 1994 Nov; 21(4):593-9. PubMed ID: 7974892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis.
    Abel EJ; Margulis V; Bauman TM; Karam JA; Christensen WP; Krabbe LM; Haddad A; Golla V; Wood CG
    BJU Int; 2016 Jun; 117(6B):E87-94. PubMed ID: 26305276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence.
    Grüllich C; Vallet S; Hecht C; Duensing S; Hadaschik B; Jäger D; Hohenfellner M; Pahernik S
    Urol Oncol; 2016 May; 34(5):238.e9-17. PubMed ID: 26739671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
    Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
    BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local recurrence of renal cell carcinoma after nephrectomy].
    Pereverzev AS; Shchukin DV; Iliukhin IuA
    Urologiia; 2003; (6):14-8. PubMed ID: 14708237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and Regional Recurrences of Clinically Localized Renal Cell Carcinoma after Nephrectomy: A 15 Year Institutional Experience with Prognostic Features and Oncologic Outcomes.
    Ray S; Cheaib JG; Biles MJ; Pineault KG; Johnson MH; Ged YMA; Markowski MC; Singla N; Allaf ME; Pierorazio PM
    Urology; 2021 Aug; 154():201-207. PubMed ID: 33864855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of locally recurrent renal cell carcinoma after nephrectomy.
    Tanguay S; Pisters LL; Lawrence DD; Dinney CP
    J Urol; 1996 Jan; 155(1):26-9. PubMed ID: 7490850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical margin does not influence recurrence rate in pT1 clear cell renal cell carcinoma after partial nephrectomy: A multicenter study.
    Kang HW; Lee SK; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
    J Surg Oncol; 2016 Jul; 114(1):70-4. PubMed ID: 27074886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.